Comparative Evaluation of AI-Based and Non-AI Genomic Biomarkers for Predicting Lung Cancer Treatment Response: A Systematic Review
: Objectives: Lung cancer remains the leading cause of cancer-related mortality worldwide, and treatment response varies substantially across patients. Conventional genomic biomarkers such as EGFR, PD-L1, and tumor mutational burden (TMB) are widely used in precision oncology but have important limitations. This system...